CosmetaLife®

Gel-Del® is focused on bringing CosmetaLife™, its superior product for wrinkle treatment to the cosmetic augmentation market by the fourth quarter of 2008. This market already generates about $1 billion of annual revenue and is growing every year at increasing rates with little more than mediocre products (2003-04 increased 35%). Gel-Del's business plan includes the formation of the subsidiary Cosmeta™Corp, a cosmetic biomaterials company that designs and produces cosmetic augmentation products. After the CosmetaLife™ launch, Cosmeta™Corp expects to develop additional products in the cosmetic augmentation marketplace.
Quelle: http://www.gel-del.com/cosmeta.htm